Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Lund-Johansen F"'
Autor:
Wüsthoff LEC; Unit for Clinical Research on Addictions, Oslo University Hospital, PO Box 4959 Nydalen, Oslo, 0424, Norway. linwus@ous-hf.no.; Norwegian Centre for Addiction Reasearch, Institute of Clinical Medicine, University of Oslo, PO Box 1039 Blindern, Oslo, 0315, Norway. linwus@ous-hf.no., Lund-Johansen F; Department of Immunology, Oslo University Hospital, PO Box 4950 Nydalen, Oslo, 0424, Norway.; ImmunoLingo Convergence Center, Institute of Clinical Medicine, University of Oslo, Gaustadalleen 21, Oslo, 0349, Norway.; Institute of Clinical Medicine, University of Oslo, PO Box 1171 Blindern, Oslo, 0318, Norway.; Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, PO Box 1171 Blindern, 0318, Oslo, Norway., Henriksen K; Agency for Social and Welfare Services, Oslo Municipality, PO Box 30 Sentrum, Oslo, 0101, Norway.; Student Health Services, Student Welfare Services in Oslo, Problemveien 9, Oslo, 0313, Norway., Wildendahl G; Agency for Social and Welfare Services, Oslo Municipality, PO Box 30 Sentrum, Oslo, 0101, Norway., Jacobsen JA; Agency for Social and Welfare Services, Oslo Municipality, PO Box 30 Sentrum, Oslo, 0101, Norway., Gomes L; Agency for Social and Welfare Services, Oslo Municipality, PO Box 30 Sentrum, Oslo, 0101, Norway., Anjum HS; Agency for Social and Welfare Services, Oslo Municipality, PO Box 30 Sentrum, Oslo, 0101, Norway., Barlinn R; Department of Microbiology, Oslo University Hospital, PO Box 4950 Nydalen, Oslo, 0424, Norway., Kran AB; Division of Infection Control, Norwegian Institute of Public Health, PO Box 222 Skøyen, Oslo, 0213, Norway., Munthe LA; Department of Immunology, Oslo University Hospital, PO Box 4950 Nydalen, Oslo, 0424, Norway.; KG Jebsen Centre for B cell Malignancies, and Precision Immunotherapy Alliance, Institute of Clinical Medicine, University of Oslo, PO Box 4950 Nydalen, Oslo, 0424, Norway., Vaage JT; Department of Immunology, Oslo University Hospital, PO Box 4950 Nydalen, Oslo, 0424, Norway.; Institute of Clinical Medicine, University of Oslo, PO Box 1171 Blindern, Oslo, 0318, Norway.
Publikováno v:
Harm reduction journal [Harm Reduct J] 2024 Jun 19; Vol. 21 (1), pp. 120. Date of Electronic Publication: 2024 Jun 19.
Autor:
Meyer S; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway., Blaas I; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway., Bollineni RC; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway., Delic-Sarac M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway., Tran TT; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway., Knetter C; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway., Dai KZ; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway., Madssen TS; Department of Circulation and Medical Imaging, NTNU, 7030 Trondheim, Norway., Vaage JT; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway., Gustavsen A; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway., Yang W; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway., Nissen-Meyer LSH; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway., Douvlataniotis K; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway., Laos M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway; Institute of Biomedicine and Translational Medicine, Faculty of Medicine, University of Tartu, 50411 Tartu, Estonia., Nielsen MM; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway., Thiede B; Department of Biosciences, University of Oslo, 0371 Oslo, Norway., Søraas A; Department of Microbiology, Oslo University Hospital, 0424 Oslo, Norway., Lund-Johansen F; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway; ImmunoLingo Convergence Center, University of Oslo, 0372 Oslo, Norway., Rustad EH; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway. Electronic address: ehrustad@gmail.com., Olweus J; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, 0379 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway. Electronic address: johanna.olweus@medisin.uio.no.
Publikováno v:
Cell reports [Cell Rep] 2023 Jan 31; Vol. 42 (1), pp. 111995. Date of Electronic Publication: 2023 Jan 09.
Autor:
Tunheim G; Division of Infection Control, Norwegian Institute of Public Health (NIPH), Oslo, Norway., Rø GØI; Division of Infection Control, Norwegian Institute of Public Health (NIPH), Oslo, Norway., Chopra A; Department of Immunology, Oslo University Hospital, Oslo, Norway., Aase A; Division of Infection Control, Norwegian Institute of Public Health (NIPH), Oslo, Norway., Kran AB; Division of Infection Control, Norwegian Institute of Public Health (NIPH), Oslo, Norway., Vaage JT; Department of Immunology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Lund-Johansen F; Department of Immunology, Oslo University Hospital, Oslo, Norway., Hungnes O; Division of Infection Control, Norwegian Institute of Public Health (NIPH), Oslo, Norway.
Publikováno v:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2022 Nov; Vol. 16 (6), pp. 1004-1013. Date of Electronic Publication: 2022 Jun 30.
Autor:
Lerum TV; Department of Pulmonary Medicine, Oslo University Hospital Ullevål, Nydalen, Postboks 4950, 0424, Oslo, Norway. tori.lerum@gmail.com.; Institute of Clinical Medicine, University of Oslo, Blindern, Postboks 1171, 0318, Oslo, Norway. tori.lerum@gmail.com., Maltzahn NN; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway.; Department of Biostatistics, Oslo Centre for Biostatistics and Epidemiology, University of Oslo, Oslo, Norway., Aukrust P; Institute of Clinical Medicine, University of Oslo, Blindern, Postboks 1171, 0318, Oslo, Norway.; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway.; Research Institute for Internal Medicine, Oslo University Hospital, Oslo, Norway., Trøseid M; Institute of Clinical Medicine, University of Oslo, Blindern, Postboks 1171, 0318, Oslo, Norway.; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway., Henriksen KN; Department of Haematology, Oslo University Hospital, Oslo, Norway.; Hospital Pharmacies of South-Eastern Norway Enterprise, Oslo, Norway., Kåsine T; Division of Critical Care and Emergencies, Oslo University Hospital, Oslo, Norway., Dyrhol-Riise AM; Institute of Clinical Medicine, University of Oslo, Blindern, Postboks 1171, 0318, Oslo, Norway.; Department of Infectious Diseases, Oslo University Hospital, Ullevål, Oslo, Norway., Stiksrud B; Department of Infectious Diseases, Oslo University Hospital, Ullevål, Oslo, Norway., Haugli M; Infectious Diseases Department, Sørlandet Hospital SSK, Kristiansand, Norway., Blomberg B; Department of Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Kittang BR; Department of Medicine, Haraldsplass Deaconess Hospital, Bergen, Norway., Johannessen A; Institute of Clinical Medicine, University of Oslo, Blindern, Postboks 1171, 0318, Oslo, Norway.; Department of Infectious Diseases, Vestfold Hospital Trust, Tønsberg, Norway., Hannula R; Department of Infectious Diseases, Trondheim University Hospital, Trondheim, Norway., Aballi S; Department of Infectious Diseases, Østfold Hospital Trust Kalnes, Grålum, Norway., Kildal AB; Department of Anaesthesiology and Intensive Care, University Hospital of North Norway, Tromsø, Norway., Eiken R; Department of Infectious Diseases, Innlandet Hospital Trust, Lillehammer, Norway., Dahl TB; Division of Critical Care and Emergencies, Oslo University Hospital, Oslo, Norway.; Research Institute for Internal Medicine, Oslo University Hospital, Oslo, Norway., Lund-Johansen F; Division of Laboratory Medicine, Department of Immunology, Oslo University Hospital, Oslo, Norway., Müller F; Institute of Clinical Medicine, University of Oslo, Blindern, Postboks 1171, 0318, Oslo, Norway.; Department of Microbiology, Oslo University Hospital, Oslo, Norway., Rodriguez JR; Department of Radiology and Nuclear Medicine, Oslo University Hospital Ullevål, Oslo, Norway., Meltzer C; Department of Radiology and Nuclear Medicine, Oslo University Hospital Ullevål, Oslo, Norway., Einvik G; Institute of Clinical Medicine, University of Oslo, Blindern, Postboks 1171, 0318, Oslo, Norway.; Department of Pulmonary Medicine, Akershus University Hospital, Lørenskog, Norway., Ueland T; Institute of Clinical Medicine, University of Oslo, Blindern, Postboks 1171, 0318, Oslo, Norway.; Research Institute for Internal Medicine, Oslo University Hospital, Oslo, Norway., Olsen IC; Department of Research Support for Clinical Trials, Oslo University Hospital, Oslo, Norway., Barratt-Due A; Division of Critical Care and Emergencies, Oslo University Hospital, Oslo, Norway.; Department of Immunology, University of Oslo, Oslo, Norway., Aaløkken TM; Institute of Clinical Medicine, University of Oslo, Blindern, Postboks 1171, 0318, Oslo, Norway.; Department of Radiology and Nuclear Medicine, Oslo University Hospital Ullevål, Oslo, Norway., Skjønsberg OH; Department of Pulmonary Medicine, Oslo University Hospital Ullevål, Nydalen, Postboks 4950, 0424, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Blindern, Postboks 1171, 0318, Oslo, Norway.
Publikováno v:
Scientific reports [Sci Rep] 2021 Dec 01; Vol. 11 (1), pp. 23205. Date of Electronic Publication: 2021 Dec 01.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.